Increased Zinc Serum Level: New Clues in Babol Stroke Patients, Northern Iran

Table 1

Evaluation of different variable with severity and statistical society.

Variable	subgroup	Statistical Society		value	Severity			value
		Control	Patient		Mild	Moderate	Severe
Sex	Male	45 (45)	47 (47)	0.87	34 (46)	10 (42)	3 (100)	0.16
	Female	55 (55)	53 (53)		39 (54)	14 (58)	0 (0)
Age	60–69	55 (55)	54 (54)	0.99	37 (51)	16 (67)	1 (33.3)
	70–79	26 (26)	27 (27)		21 (29)	5 (20)	1 (33.3)	0.64
	Above 80	19 (19)	19 (19)		15 (20)	3 (13)	1 (33.3)
IHD	No	98 (98)	70 (70)	<0.0001	51 (70)	18 (75)	1 (33.3)
	Yes	2 (2)	30 (30)		22 (30)	6 (25)	2 (66.7)	0.33
DM	No	68 (68)	62 (62)	0.45	47 (64)	14 (58)	1 (33.3)
	Yes	32 (32)	38 (38)		26 (36)	10 (42)	2 (66.7)	0.50
HTN	No	43 (43)	35 (35)	0.31	27 (31)	8 (33)	0 (0)
	Yes	57 (57)	65 (65)		46 (69)	16 (67)	3 (100)	0.41
HLP	No	50 (50)	65 (65)	0.04	47 (64)	17 (71)	1 (33.3)
	Yes	50 (50)	35 (35)		26 (36)	7 (29)	2 (66.7)	0.42
Smoker	No	82 (82)	72 (72)	0.13	56 (77)	15 (62)	1 (33.3)
	Yes	18 (18)	28 (28)		17 (23)	9 (38)	2 (66.7)	0.12
Zinc; serum; level	Under 70	20 (20)	3 (3)	<0.0001	2 (2.7)	1 (4.2)	0 (0)	0.79
	70–120	54 (54)	25 (25)		20 (27.4)	5 (20.8)	0 (0)
	Above 120	26 (26)	72 (72)		51 (69.9)	18 (75)	3 (100)
Type	Ischemic	0 (0)	90 (90)	-	67 (91)	21 (87)	2 (66.7)	0.32
	Hemorrhagic	0 (0)	10 (10)		6 (9)	3 (13)	1 (33.3)

Note. Ischemic heart disease (IHD), diabetes mellitus (DM), hypertension (HTN), and hyperlipidemia (HLP).